Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study)
在病毒学抑制的 HIV 成人患者中,改用比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺与继续使用多替拉韦/拉米夫定相比,炎症和代谢结果相当(INSTINCT/GESIDA10918 研究)
期刊:Clinical Infectious Diseases
影响因子:
doi:10.1093/cid/ciaf565
Serrano-Villar, Sergio; Martín-Pedraza, Laura; Tiraboschi, Juan; Novella, María; Cabello-Úbeda, Alfonso; López-Cortés, Luis; Busca, Carmen; Torralba, Miguel; Crusells, María José; Hidalgo-Tenorio, Carmen; Estrada, Vicente; Del Amo-de Palacios, Ana; Díaz de Santiago, Alberto; Fons-Contreras, María; Santos, Jesús; Bernal, Enrique; Montero-Alonso, Marta; Troya, Jesús; Blanco, José Ramón; Burgos, Joaquín; de Miguel, Marta; Moreno, Santiago